Axa S.A. Harmony Biosciences Holdings, Inc. Call Options Transaction History
Axa S.A.
- $33.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HRMY
# of Institutions
290Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$191 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$148 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$47.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$45.7 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.71B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...